Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

76
Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders

Transcript of Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Page 1: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Neurology Ch. 65

Management of patients with oncologic or degenerative neurologic

disorders

Page 2: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

Pathophysiology• Primary– Originating from the

brain

• Secondary– Originating outside the

brain– Metastasis

Page 3: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

• Malignant– Tend to become

progressively worse– Anaplasia

• Cell distortion

– Invasive

• Benign– No malignant or

recurrent

Page 4: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

• Presence of lesion • Compression of blood

vessels • Ischemia • Edema • I-ICP

Page 5: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

• Are brain tumors a disorder of the CNS, PNS or Both the CNS and PNS?

A. CNSB. PNSC. Both CNS & PNS

Page 6: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Primary-Brain Tumors

Etiology• Unknown

Page 7: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

Clinical manifestations• Depends on– Size– Location

Page 8: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

4 main S&S• I-ICP– Cushing sign– H/A– Vomiting– Visual disturbances

• Seizures• Hydrocephalus• Alt Pituitary function

• Cancer cells being attacked by immune system

Page 9: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

Localized S&S• Frontal– Personality changes– Emotional changes

• Occipital– Visual impairment– Visual hallucinations

• Cerebellum– Impaired equilibrium– Impaired coordination

Page 10: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

Diagnosis• CT• MRI

Page 11: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Primary - Brain Tumors

Medical management• Radiation• Chemotherapy• Pharmaceutical– Corticosteroids– Anti-convulsants

• Surgery

• Tug McGraw

Page 12: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Secondary-Brain Tumor

3 treatment options• No treatment– Death < 1 month

• Tx w/ corticosteroids only– Death < 2 months

• Tx with radiation– Death 3-6 months

Page 13: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Secondary-Brain Tumor

Pharmacology• Corticosteroids– Dexamethasone– Prednisone

• Osmotic Diuretic– Mannitol

• Anti-convulsants– Dilantin

• Morphine

Page 14: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

Nursing Management• Aspiration• Alt. nutrition– Cachexia

• Weak emaciate condition

• Neuro checks• Photophobia• Seizure precaution• Anxiety

Page 15: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

• What S&S are associated with frontal lobe, occipital lobe and cerebellum tumors?

• What diet would you expect a patient with brain cancer to be on?

• The S&S are associated with increase intracranial pressure?

Page 16: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Brain Tumors

• What are the difference between malignant tumors and benign tumors?

• What does metastasis refer to?• What are risk factors of cancer?• What does remission mean or refer to?

Page 17: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• First described by James Parkinson 1817

• A progressive brain disorder characterized by the degeneration of dopamine secreting neurons deep in the cerebral hemisphere in a part of the brain called the basal ganglia

Page 18: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• Basal Ganglia– Controls movement

• Dopamine– Inhibitory

neurotransmitter in the basal ganglia

• Acetylcholine– Excitatory

neurotransmitter in the basal ganglia

Page 19: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• Without dopamine, inhibitory influences are lost and excitatory mechanisms are unopposed

• Neurons of basal ganglia are over stimulated

• Excess muscle tone, tremors & rigidity

Page 20: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• Is Parkinson's disease a disorder of the CNS, PNS or both the CNS & PNS?

A. CNSB. PNSC. Both PNS & CNS

Page 21: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Clinical manifestations• Onset– Abrupt

• Age of on set– 60

• Men vs. Women– Men > women

• First Symptom– Fine tremors in hands or

feet

Page 22: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

3 clinical signs• Tremors• Rigidity• Bradykinesia

Page 23: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• Tremors– Resting tremor– with activity– tremor when…

• Walking• Anxious

– Sensation of heat– Calorie burning!

Page 24: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• Rigidity– Stiffness

• Neck• Trunk• Shoulders

– Posture• Head bowed• Body bent forward• Arms flexed• Thumbs turned into

palms• Knees bent (slightly)

Page 25: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• Bradykinesia– Slow movement– Akinesia

• Loss of movement• Esp face

– Expressionless

– Slow speech• Dysphonia

– Dysphagia• Drooling

Page 26: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• Bradykinesia– Gait

• Shuffled• Festination

– Fall forward d/t posture

Page 27: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Diagnosis• S&S• Positive response to

Levodopa

Page 28: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Medical Management• dopamine– (blood brain barrier)

Page 29: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• Anti-Parkinsonian medications– Levodopa

• Converts into dopamine in the basal ganglia

• Works best in 1st few years of disease effectiveness wanes

• S/E Dizzy (esp when first get up) get up slowly!

Page 30: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• Anti-Parkinsonian medications– Sinemet

• Prevents the breakdown of levodopa outside the brain

Page 31: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Nursing Management• Assessment– Affect on ADL’s– Dysfunction– S/E of meds

Page 32: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Nursing Management• Improving mobility– Exercise– ROM– Warm baths– Massage– PT

• gait program

Page 33: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Nursing Management• Enhancing Self-care– Encouragement– Adaptive devices– OT

Page 34: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Nursing Management• Improving Bowel

elimination – Constipation– Bowel routine– Fluids– Fiber– Raised toilet

Page 35: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Nursing Management• Nutritional deficit– Slow process– Meds dry mouth– Chewing & Swallowing– Weights– Supplement– Dietician

• FORK!

Page 36: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Nursing Management• Enhance swallowing– Upright position– Semi-solid food– Thick liquids

Page 37: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

Nursing Management• Communication– Speak slow– Short sentences– Deep breath before

speaking– SLP

Page 38: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• With PD it is known which neurotransmitter is lacking in the brain and scientists are able to duplicate this neurotransmitter. Why are we then unable to cure PD?

• PD type deterioration of the nerve cells of the brain reduces the amount of what neurotransmitter?

• Because of the inability to cure PD at this time, PD is frequently treated with which medications?

• What are the side effects of these meds?

Page 39: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• To promote optimal functions, which activity could the nurse recommend as being beneficial to a patient with PD ?

• What would be of value in helping a patient with PD communicate with the medical team?

• Is PD a disease of the CNS, PNS or both?

Page 40: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Parkinson’s Disease

• During an assessment, what signs and symptoms can the nurse anticipate a patient with Parkinson’s to exhibit?

• What nursing diagnosis would be priority for a patient with Parkinson’s?

• Describe the muscle tone of a patient with Parkinson’s (medical terms)

• What interventions can be used to address the issue of nonintention tremors?

Page 41: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Huntington’s Disease

• AKA– Huntinton’s Chorea

• Pathophysology– Rare– Genetic

• George Huntington

Page 42: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Huntington’s Disease

• The disease is characterized as degeneration of the cerebral cortex and the basal ganglia

Page 43: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Huntington’s Disease

– Which causes chronic progressive chorea • Bizzare involuntary dance-

like movements

– And mental deterioration

– Ending in dementia and death

• Loss of GABA (inhibitory neurotransmitter)

Page 44: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Huntington’s Disease

Clinical manifestations• Involuntary choreiform• Diminished during sleep• Facial tics/grimacing• Paranoia &

hallucinations• Appetite– Ravenous

• Emotions– Labile

Page 45: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Huntington’s Disease

Diagnosis• DNA testing

Page 46: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Huntington’s Disease

Medical management• No treatment• Meds to tics– Chlorpromazine

(Thorazine)• Meds to hallucination,

delusions, angry outbursts– Haloperidol (Haldol)

• Anti-psychotics

Page 47: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Huntington’s Disease

Nursing Management• Family support• Diet• Ambulatory• Safety

Page 48: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Huntington’s Disease

• Is Huntington’s a disease of the CNS, PNS, or both?

• What dietary changes might be appropriate for a patient with Huntington’s disease?

• Describe the pathophysiology of Huntington’s disease.

• What is the etiology of Huntington’s disease?

• How is Huntington’s disease different from Parkinson’s disease?

Page 49: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Huntington’s Disease

• What medications are used to help with tics and uncontrolled movements associated with Huntington Chorea?

• If a patient expresses suicidal thought, what are the correct nursing management interventions

• Huntington’s Chorea is characterized by what (what does it look like)?

• Name five nursing interventions for a patient with Huntington’s disease

Page 50: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

Pathophysiology• Degenerative motor

neuron disease that affects UMN & LMN lying within the brain, spinal cord and peripheral nerves

• Lou Gehrig

Page 51: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

• The myelin sheaths are destroyed and replaced with scar tissue

Page 52: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

• Does not affect CN– 3– 4– 6

• The patient is therefore able to – Blink– Move eye

Page 53: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

• Cognition is left intact!

Page 54: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

• Is ALS a disorder of the CNS, PNS or both the CNS and PNS?

A. CNSB. PNSC. Both CNS & PNS

Page 55: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

Etiology• Unknown• Men vs. Women– Men > Women

Page 56: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

Clinical manifestations• Progressive muscle

weakness• Atrophy• Spasity• Dysphagia• Dysarthria• Jaw Clonus• Tongue fasciculation

Page 57: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

Clinical Manifestations• No sensory loss• Death within 5 years– Resp. failure– Bulbar paralysis

Page 58: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

Diagnosis• S&S only– No dx screen

Page 59: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

Medical Management• Baclofen (Lioresal)• Diazepan (Valium)– Spasticity

• Mechanical Ventilator

Page 60: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

Nursing Management• Respiratory• ADL’s• Nutritional support• Emotional support• Advanced directive

Page 61: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Amyotrophic Lateral Sclerosis

• Amyotrophic Lateral Sclerosis is manifested by what?

• What are the classic signs and symptoms of this disease?

• What are fasciculations?• Amyotrophic lateral sclerosis effects UMN, LMN or

both?• CNS? PNS? Both?• What is the treatment methodology for ALS?• What is the pathophysiology of ALS?

Page 62: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Herniated Disc

• AKA– Ruptured disc– Slipped disc– Degenerative disc

disease

Page 63: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Herniated Disc

• Anatomy– The interverterbral disc

is a cartilaginous plate that forms a cushion between the vertebral body

– Nucleus pulposus– Protrudes– Nerve compression

Page 64: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Herniated Disc

Etiology• Age• Trauma

Page 65: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Herniated Disc

Clinical Manifestations• Cervical– Location

• C5-6• C6-7

– Pain • Neck • Shoulder• ? Heart attack?

Page 66: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Herniated Disc

• Lumbar– Location

• L4-5• L5-S1

– Pain• Low back• Sciatica

– Relieved with• Bed rest

Page 67: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Herniated Disc

Medical Management• Conservative - cervical– Immobilization

• Collar

– Isometric exercises– Pain relief

• Hot packs• Analgesics• Muscle relaxant med• Anti inflammatory med

Page 68: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Herniated Disc

Medical Management• Conservative - lumbar– Bed rest

• Firm mattress

– Pain relief• Hot packs• Analgesics• Massage• Muscle relaxant med• Anti inflammatory med

Page 69: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Herniated Disc

Medical management• Surgery – lumbar– Turning

• Log roll

– Sitting• No sitting (except BR)

– Complication• Failed Disc Syndrome

Page 70: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Herniated Disc

• What are contributing factors to a Herniated disc?

• The center of the vertebral disc is called what?

• What are the most common sites for herniated disc?

• What is Sciatica?• CNS? PNS? Both?• What is the frustrating complication post

surgery?

Page 71: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Spinal Bifida

Pathophysiology• Neural Tube defect• Incomplete closure of

the vertebrae• 3 Levels– Spina Bifida Occulta– Meningocele– Myelomeningocele

Page 72: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Spinal Bifida

• Meningocele • Myelomeningocele

Page 73: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Spinal Bifida

Etiology• Folic acid deficiency

during pregnancy– Esp 1st month

Page 74: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Spinal Bifida

Diagnosis• Ultrasound• levels of fetal protein– Alpha fetoprotein

Page 75: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

Spinal Bifida

• What food contain folic Acid?– Greens– Asparagus– Broccoli– Cauliflower– Corn– Green Beans or Peas– Sweet Potato– Cabbage or Coleslaw

– Black Beans– Lentils– Peas– Peanuts

Page 76: Neurology Ch. 65 Management of patients with oncologic or degenerative neurologic disorders.

• What deficit is associated with spina bifida?• What diagnostic test is used to detect spina

bifida invitro?• Name three foods high in folic acid.• Describe the difference between Spina

Bifida occult, meningocele and myelomeningocele.

• CNS? PNS? Both?